Mary Soliman
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Virology 5
- HIV Research and Treatment 5
-
- HIV/AIDS Research and Interventions 3
- HIV/AIDS drug development and treatment 2
- Co-authors
- Robert F. Siliciano (2 shared papers)Douglas D. Richman (1 shared paper)Jun Lai (1 shared paper)Ya‐Chi Ho (1 shared paper)Rebecca Hoh (1 shared paper)Alexandra J. Murray (1 shared paper)Sarah B. Laskey (1 shared paper)Steven M. Lada (1 shared paper)
- Journals
- Science Advances (1 paper)Nature Medicine (1 paper)AIDS (1 paper)Current HIV/AIDS Reports (1 paper)Cell Host & Microbe (1 paper)
- Partner nations
- United States
In The Last Decade
Mary Soliman
7 papers receiving 659 citations
Mary Soliman's Hit Papers
Peers
Comparison fields: 5 of 53
- Virology 525
- Infectious Diseases 374
- Hepatology 76
- Immunology 202
- Emergency Medicine 47
Countries citing papers authored by Mary Soliman
This map shows the geographic impact of Mary Soliman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Soliman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Soliman more than expected).
Fields of papers citing papers by Mary Soliman
This network shows the impact of papers produced by Mary Soliman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Soliman. The network helps show where Mary Soliman may publish in the future.
Co-authors
The 25 scholars most cited alongside Mary Soliman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Defective proviruses rapidly accumulate during acute HIV-1 infection Hit paper breakdown → | 2016 | 515 |
| 2 | 2018 | 66 | |
| 3 | 2018 | 50 | |
| 4 | 2017 | 14 | |
| 5 | 2017 | 11 | |
| 6 | 2017 | 2 | |
| 7 | 2019 | 1 | |
| 8 | 2020 | 0 |
About Mary Soliman
Mary Soliman is a scholar working on Virology, Infectious Diseases, Immunology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine, having authored 8 papers that have together received 659 indexed citations. Recurring topics across this work include HIV Research and Treatment (5 papers), HIV/AIDS Research and Interventions (3 papers), Immune Cell Function and Interaction (3 papers), HIV/AIDS drug development and treatment (2 papers), interferon and immune responses (1 paper), Pharmaceutical Practices and Patient Outcomes (1 paper), Blood groups and transfusion (1 paper) and Platelet Disorders and Treatments (1 paper). The work is most often cited by research in Virology (525 citations), Infectious Diseases (374 citations), Hepatology (76 citations), Immunology (202 citations) and Emergency Medicine (47 citations). Mary Soliman has collaborated with scholars based in United States. Frequent co-authors include Robert F. Siliciano, Douglas D. Richman, Jun Lai, Ya‐Chi Ho, Rebecca Hoh, Alexandra J. Murray, Sarah B. Laskey, Steven M. Lada, Katherine M. Bruner and Adam A. Capoferri. Their work appears in journals such as Science Advances, Nature Medicine, AIDS, Current HIV/AIDS Reports and Cell Host & Microbe.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.